Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic
proliferation characterized by a variable and often unpredictable clinical course. Currently …

Desmoid tumors describe a rare monoclonal, fibroblastic proliferation characterized by a
variable and often unpredictable clinical course. Although histologically benign, desmoids …

Purpose Desmoid tumors are mesenchymal fibroblastic/myofibroblastic proliferations with
locoregional aggressiveness and high ability to recur after initial treatment. We present the …

Desmoid fibromatosis is a rare, nonmetastatic neoplasm marked by local invasiveness and
relentless recurrence. Molecular determinants of desmoid recurrence remain obscure. β …

Purpose Surgery is still the standard treatment for desmoid-type fibromatosis (DF). Recently,
the Institut Gustave Roussy (IGR), Villejuif, France, reported a series of patients treated with …

Chest wall tumors are a relatively uncommon disease in clinical practice. Most of the
published studies about chest wall tumors are usually single-center retrospective studies …

Desmoid-type fibromatosis (DF) is a rare monoclonal, fibroblastic proliferation characterised
by a variable and often unpredictable clinical course. It may affect nearly all parts of the body …

Purpose The relevance of the initial observational approach for desmoid tumors (DTs)
remains unclear. We investigated a new conservative management treatment for primary …

OBJECTIVE: To evaluate the impact of surgery as first-line treatment on event-free survival
(EFS) of primary aggressive fibromatosis. PATIENTS AND METHODS: Treatments were …

Background Imatinib evaluated as a new treatment option in patients with recurrent or
established progressive aggressive fibromatosis/desmoid tumor (AF/DT). Patients and …